| 6.9 |
20.7 |
GO:0072223 |
metanephric glomerular mesangium development(GO:0072223) metanephric glomerular mesangial cell proliferation involved in metanephros development(GO:0072262) |
| 4.5 |
13.5 |
GO:0060166 |
olfactory pit development(GO:0060166) |
| 3.3 |
9.9 |
GO:1903279 |
regulation of calcium:sodium antiporter activity(GO:1903279) |
| 2.3 |
6.9 |
GO:0035622 |
intrahepatic bile duct development(GO:0035622) renal vesicle induction(GO:0072034) |
| 2.2 |
6.7 |
GO:0021893 |
cerebral cortex GABAergic interneuron fate commitment(GO:0021893) |
| 2.2 |
4.4 |
GO:0061054 |
dermatome development(GO:0061054) regulation of dermatome development(GO:0061183) |
| 1.9 |
7.7 |
GO:0006867 |
asparagine transport(GO:0006867) glutamine transport(GO:0006868) |
| 1.7 |
5.2 |
GO:0043465 |
regulation of fermentation(GO:0043465) negative regulation of fermentation(GO:1901003) |
| 1.5 |
7.5 |
GO:0034441 |
plasma lipoprotein particle oxidation(GO:0034441) |
| 1.4 |
5.8 |
GO:0019372 |
lipoxygenase pathway(GO:0019372) |
| 1.4 |
8.2 |
GO:0060718 |
chorionic trophoblast cell differentiation(GO:0060718) |
| 1.3 |
4.0 |
GO:0050748 |
negative regulation of receptor biosynthetic process(GO:0010871) negative regulation of lipoprotein metabolic process(GO:0050748) |
| 1.3 |
5.3 |
GO:0099624 |
regulation of atrial cardiac muscle cell membrane repolarization(GO:0060372) atrial cardiac muscle cell membrane repolarization(GO:0099624) |
| 1.3 |
9.2 |
GO:2000124 |
regulation of endocannabinoid signaling pathway(GO:2000124) |
| 1.2 |
11.8 |
GO:0090527 |
actin filament reorganization(GO:0090527) |
| 1.1 |
4.4 |
GO:0046469 |
platelet activating factor biosynthetic process(GO:0006663) platelet activating factor metabolic process(GO:0046469) |
| 0.9 |
2.6 |
GO:0061743 |
motor learning(GO:0061743) |
| 0.8 |
2.5 |
GO:0019074 |
viral genome packaging(GO:0019072) viral RNA genome packaging(GO:0019074) |
| 0.8 |
3.4 |
GO:0034454 |
microtubule anchoring at centrosome(GO:0034454) |
| 0.8 |
4.0 |
GO:0035022 |
positive regulation of Rac protein signal transduction(GO:0035022) |
| 0.8 |
2.4 |
GO:0072076 |
hyaluranon cable assembly(GO:0036118) nephrogenic mesenchyme development(GO:0072076) regulation of hyaluranon cable assembly(GO:1900104) positive regulation of hyaluranon cable assembly(GO:1900106) |
| 0.8 |
2.3 |
GO:2000418 |
positive regulation of eosinophil migration(GO:2000418) |
| 0.7 |
14.7 |
GO:0050650 |
chondroitin sulfate proteoglycan biosynthetic process(GO:0050650) |
| 0.7 |
2.0 |
GO:0006001 |
fructose catabolic process(GO:0006001) fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate(GO:0061624) glycolytic process through fructose-1-phosphate(GO:0061625) |
| 0.6 |
3.8 |
GO:1990118 |
sodium ion import across plasma membrane(GO:0098719) sodium ion import into cell(GO:1990118) |
| 0.6 |
3.8 |
GO:0061365 |
positive regulation of triglyceride lipase activity(GO:0061365) |
| 0.6 |
1.9 |
GO:1903054 |
negative regulation of extracellular matrix organization(GO:1903054) |
| 0.6 |
1.8 |
GO:0032058 |
positive regulation of translational initiation in response to stress(GO:0032058) |
| 0.6 |
1.7 |
GO:0035621 |
ER to Golgi ceramide transport(GO:0035621) ceramide transport(GO:0035627) |
| 0.6 |
1.7 |
GO:0061537 |
glycine secretion(GO:0061536) glycine secretion, neurotransmission(GO:0061537) |
| 0.6 |
5.0 |
GO:0042118 |
endothelial cell activation(GO:0042118) |
| 0.6 |
1.7 |
GO:0048208 |
vesicle targeting, rough ER to cis-Golgi(GO:0048207) COPII vesicle coating(GO:0048208) |
| 0.5 |
1.1 |
GO:2000286 |
receptor internalization involved in canonical Wnt signaling pathway(GO:2000286) |
| 0.5 |
3.2 |
GO:0051541 |
elastin metabolic process(GO:0051541) |
| 0.5 |
5.2 |
GO:0048681 |
negative regulation of axon regeneration(GO:0048681) |
| 0.5 |
1.5 |
GO:0016321 |
female meiosis chromosome segregation(GO:0016321) |
| 0.5 |
1.5 |
GO:0061535 |
glutamate secretion, neurotransmission(GO:0061535) |
| 0.5 |
3.5 |
GO:0043569 |
negative regulation of insulin-like growth factor receptor signaling pathway(GO:0043569) |
| 0.5 |
8.4 |
GO:0030574 |
collagen catabolic process(GO:0030574) |
| 0.5 |
1.5 |
GO:0043379 |
memory T cell differentiation(GO:0043379) negative regulation of isotype switching to IgE isotypes(GO:0048294) |
| 0.5 |
1.0 |
GO:0051151 |
negative regulation of smooth muscle cell differentiation(GO:0051151) |
| 0.5 |
6.7 |
GO:0038063 |
collagen-activated tyrosine kinase receptor signaling pathway(GO:0038063) |
| 0.5 |
2.4 |
GO:0097116 |
gephyrin clustering involved in postsynaptic density assembly(GO:0097116) |
| 0.5 |
1.4 |
GO:0021577 |
hindbrain structural organization(GO:0021577) cerebellum structural organization(GO:0021589) |
| 0.5 |
1.4 |
GO:0035864 |
response to potassium ion(GO:0035864) cellular response to potassium ion(GO:0035865) |
| 0.4 |
2.2 |
GO:0042518 |
negative regulation of tyrosine phosphorylation of Stat3 protein(GO:0042518) |
| 0.4 |
2.7 |
GO:0070863 |
positive regulation of protein exit from endoplasmic reticulum(GO:0070863) |
| 0.4 |
19.9 |
GO:0070206 |
protein trimerization(GO:0070206) |
| 0.4 |
8.8 |
GO:0051044 |
positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
| 0.4 |
1.2 |
GO:0045414 |
regulation of muscle hyperplasia(GO:0014738) muscle hyperplasia(GO:0014900) regulation of interleukin-8 biosynthetic process(GO:0045414) |
| 0.4 |
5.2 |
GO:0060746 |
parental behavior(GO:0060746) |
| 0.4 |
2.3 |
GO:0002934 |
desmosome organization(GO:0002934) |
| 0.4 |
3.1 |
GO:0033089 |
positive regulation of T cell differentiation in thymus(GO:0033089) positive regulation of thymocyte aggregation(GO:2000400) |
| 0.4 |
2.7 |
GO:0072602 |
interleukin-4 secretion(GO:0072602) |
| 0.4 |
3.8 |
GO:0051608 |
organic cation transport(GO:0015695) histamine transport(GO:0051608) |
| 0.4 |
1.4 |
GO:0051599 |
response to hydrostatic pressure(GO:0051599) |
| 0.4 |
1.4 |
GO:0031581 |
hemidesmosome assembly(GO:0031581) |
| 0.3 |
3.5 |
GO:0060136 |
embryonic process involved in female pregnancy(GO:0060136) |
| 0.3 |
1.0 |
GO:1905050 |
positive regulation of metalloendopeptidase activity(GO:1904685) positive regulation of metallopeptidase activity(GO:1905050) |
| 0.3 |
4.5 |
GO:0042759 |
long-chain fatty acid biosynthetic process(GO:0042759) |
| 0.3 |
2.0 |
GO:1900246 |
positive regulation of RIG-I signaling pathway(GO:1900246) |
| 0.3 |
5.7 |
GO:0034142 |
toll-like receptor 4 signaling pathway(GO:0034142) |
| 0.3 |
1.0 |
GO:0090298 |
positive regulation of fat cell proliferation(GO:0070346) negative regulation of mitochondrial DNA replication(GO:0090298) |
| 0.3 |
2.2 |
GO:0071361 |
cellular response to ethanol(GO:0071361) |
| 0.3 |
3.1 |
GO:0032876 |
negative regulation of DNA endoreduplication(GO:0032876) |
| 0.3 |
3.4 |
GO:0042473 |
outer ear morphogenesis(GO:0042473) |
| 0.3 |
3.7 |
GO:1900383 |
regulation of synaptic plasticity by receptor localization to synapse(GO:1900383) |
| 0.3 |
5.2 |
GO:0048679 |
regulation of axon regeneration(GO:0048679) |
| 0.3 |
0.6 |
GO:0042663 |
regulation of endodermal cell fate specification(GO:0042663) |
| 0.3 |
1.8 |
GO:0072539 |
T-helper 17 cell differentiation(GO:0072539) |
| 0.3 |
2.0 |
GO:0035372 |
protein localization to microtubule(GO:0035372) |
| 0.3 |
2.5 |
GO:0046643 |
regulation of gamma-delta T cell differentiation(GO:0045586) regulation of gamma-delta T cell activation(GO:0046643) |
| 0.3 |
1.1 |
GO:0043504 |
mitochondrial DNA repair(GO:0043504) |
| 0.3 |
1.0 |
GO:0014722 |
regulation of skeletal muscle contraction by calcium ion signaling(GO:0014722) |
| 0.3 |
1.3 |
GO:1900748 |
positive regulation of vascular endothelial growth factor signaling pathway(GO:1900748) |
| 0.2 |
2.0 |
GO:0014816 |
skeletal muscle satellite cell differentiation(GO:0014816) |
| 0.2 |
0.7 |
GO:0001543 |
ovarian follicle rupture(GO:0001543) |
| 0.2 |
2.0 |
GO:0050908 |
detection of light stimulus involved in visual perception(GO:0050908) detection of light stimulus involved in sensory perception(GO:0050962) |
| 0.2 |
1.7 |
GO:0048752 |
semicircular canal morphogenesis(GO:0048752) |
| 0.2 |
1.9 |
GO:0000185 |
activation of MAPKKK activity(GO:0000185) |
| 0.2 |
2.8 |
GO:0001975 |
response to amphetamine(GO:0001975) response to amine(GO:0014075) |
| 0.2 |
1.6 |
GO:0016338 |
calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
| 0.2 |
2.7 |
GO:0061299 |
retina vasculature morphogenesis in camera-type eye(GO:0061299) |
| 0.2 |
0.7 |
GO:0060753 |
regulation of mast cell chemotaxis(GO:0060753) |
| 0.2 |
2.0 |
GO:0033631 |
cell-cell adhesion mediated by integrin(GO:0033631) |
| 0.2 |
1.1 |
GO:0090234 |
regulation of kinetochore assembly(GO:0090234) |
| 0.2 |
2.6 |
GO:0060134 |
prepulse inhibition(GO:0060134) |
| 0.2 |
0.4 |
GO:0061009 |
common bile duct development(GO:0061009) |
| 0.2 |
3.6 |
GO:0048172 |
regulation of short-term neuronal synaptic plasticity(GO:0048172) |
| 0.2 |
1.1 |
GO:0070345 |
negative regulation of fat cell proliferation(GO:0070345) |
| 0.2 |
0.8 |
GO:0061010 |
gall bladder development(GO:0061010) |
| 0.2 |
1.2 |
GO:0046549 |
retinal cone cell development(GO:0046549) |
| 0.2 |
1.2 |
GO:0042795 |
snRNA transcription from RNA polymerase II promoter(GO:0042795) |
| 0.2 |
1.0 |
GO:0032911 |
nerve growth factor production(GO:0032902) negative regulation of transforming growth factor beta1 production(GO:0032911) |
| 0.2 |
1.1 |
GO:1903025 |
regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903025) |
| 0.2 |
3.6 |
GO:0006415 |
translational termination(GO:0006415) |
| 0.2 |
0.7 |
GO:1903587 |
negative regulation of peptidyl-serine dephosphorylation(GO:1902309) regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:1903587) |
| 0.2 |
4.2 |
GO:0006907 |
pinocytosis(GO:0006907) |
| 0.2 |
0.5 |
GO:0015910 |
peroxisomal long-chain fatty acid import(GO:0015910) |
| 0.2 |
3.5 |
GO:0007205 |
protein kinase C-activating G-protein coupled receptor signaling pathway(GO:0007205) |
| 0.1 |
0.7 |
GO:0006369 |
termination of RNA polymerase II transcription(GO:0006369) |
| 0.1 |
0.9 |
GO:0010571 |
positive regulation of nuclear cell cycle DNA replication(GO:0010571) |
| 0.1 |
1.4 |
GO:0030238 |
male sex determination(GO:0030238) |
| 0.1 |
0.4 |
GO:0060010 |
Sertoli cell fate commitment(GO:0060010) |
| 0.1 |
0.4 |
GO:0071921 |
establishment of sister chromatid cohesion(GO:0034085) cohesin loading(GO:0071921) regulation of cohesin loading(GO:0071922) |
| 0.1 |
0.5 |
GO:0097118 |
neuroligin clustering involved in postsynaptic membrane assembly(GO:0097118) |
| 0.1 |
0.3 |
GO:0072393 |
microtubule anchoring at microtubule organizing center(GO:0072393) |
| 0.1 |
1.9 |
GO:1902187 |
negative regulation of viral release from host cell(GO:1902187) |
| 0.1 |
1.1 |
GO:0006953 |
acute-phase response(GO:0006953) |
| 0.1 |
1.6 |
GO:0021800 |
cerebral cortex tangential migration(GO:0021800) |
| 0.1 |
5.2 |
GO:0001676 |
long-chain fatty acid metabolic process(GO:0001676) |
| 0.1 |
0.9 |
GO:0015732 |
prostaglandin transport(GO:0015732) |
| 0.1 |
0.5 |
GO:1902268 |
negative regulation of polyamine transmembrane transport(GO:1902268) |
| 0.1 |
0.8 |
GO:0006297 |
nucleotide-excision repair, DNA gap filling(GO:0006297) |
| 0.1 |
0.7 |
GO:0034047 |
regulation of protein phosphatase type 2A activity(GO:0034047) |
| 0.1 |
0.3 |
GO:0006083 |
acetate metabolic process(GO:0006083) |
| 0.1 |
0.2 |
GO:0042760 |
very long-chain fatty acid catabolic process(GO:0042760) |
| 0.1 |
2.4 |
GO:0031954 |
positive regulation of protein autophosphorylation(GO:0031954) |
| 0.1 |
0.6 |
GO:0089711 |
L-glutamate transmembrane transport(GO:0089711) |
| 0.1 |
0.6 |
GO:0097368 |
establishment of Sertoli cell barrier(GO:0097368) |
| 0.1 |
1.8 |
GO:0060236 |
regulation of mitotic spindle organization(GO:0060236) regulation of spindle organization(GO:0090224) |
| 0.1 |
0.7 |
GO:0045743 |
positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
| 0.1 |
0.7 |
GO:0043568 |
positive regulation of insulin-like growth factor receptor signaling pathway(GO:0043568) |
| 0.1 |
0.4 |
GO:1901475 |
pyruvate transmembrane transport(GO:1901475) |
| 0.1 |
1.2 |
GO:0014051 |
gamma-aminobutyric acid secretion(GO:0014051) |
| 0.1 |
0.7 |
GO:0051534 |
negative regulation of NFAT protein import into nucleus(GO:0051534) |
| 0.1 |
0.3 |
GO:0010899 |
regulation of phosphatidylcholine catabolic process(GO:0010899) |
| 0.1 |
0.6 |
GO:0010908 |
regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010908) positive regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010909) secretory granule localization(GO:0032252) canonical Wnt signaling pathway involved in positive regulation of epithelial to mesenchymal transition(GO:0044334) positive regulation of proteoglycan biosynthetic process(GO:1902730) |
| 0.1 |
0.6 |
GO:0003025 |
regulation of systemic arterial blood pressure by baroreceptor feedback(GO:0003025) |
| 0.1 |
0.8 |
GO:0098535 |
de novo centriole assembly(GO:0098535) |
| 0.1 |
0.9 |
GO:0071763 |
nuclear membrane organization(GO:0071763) |
| 0.1 |
4.2 |
GO:0060612 |
adipose tissue development(GO:0060612) |
| 0.1 |
0.3 |
GO:0006049 |
UDP-N-acetylglucosamine catabolic process(GO:0006049) |
| 0.1 |
0.9 |
GO:0060068 |
vagina development(GO:0060068) |
| 0.1 |
2.9 |
GO:0007157 |
heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0007157) |
| 0.1 |
1.0 |
GO:0034501 |
protein localization to kinetochore(GO:0034501) |
| 0.1 |
0.6 |
GO:2000601 |
positive regulation of Arp2/3 complex-mediated actin nucleation(GO:2000601) |
| 0.1 |
1.2 |
GO:0006883 |
cellular sodium ion homeostasis(GO:0006883) |
| 0.1 |
0.4 |
GO:0038030 |
non-canonical Wnt signaling pathway via MAPK cascade(GO:0038030) non-canonical Wnt signaling pathway via JNK cascade(GO:0038031) |
| 0.1 |
0.3 |
GO:0090283 |
regulation of protein glycosylation in Golgi(GO:0090283) |
| 0.1 |
1.0 |
GO:0014912 |
negative regulation of smooth muscle cell migration(GO:0014912) |
| 0.1 |
0.3 |
GO:2000325 |
nuclear-transcribed mRNA catabolic process, no-go decay(GO:0070966) regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000325) positive regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000327) |
| 0.1 |
0.5 |
GO:0071549 |
response to dexamethasone(GO:0071548) cellular response to dexamethasone stimulus(GO:0071549) |
| 0.1 |
0.3 |
GO:1900145 |
regulation of nodal signaling pathway involved in determination of left/right asymmetry(GO:1900145) regulation of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry(GO:1900175) positive regulation of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry(GO:1900224) positive regulation of mesoderm development(GO:2000382) |
| 0.1 |
1.8 |
GO:0009395 |
phospholipid catabolic process(GO:0009395) |
| 0.1 |
1.6 |
GO:0009950 |
dorsal/ventral axis specification(GO:0009950) |
| 0.1 |
0.1 |
GO:0072092 |
ureteric bud invasion(GO:0072092) |
| 0.1 |
1.3 |
GO:1902043 |
positive regulation of extrinsic apoptotic signaling pathway via death domain receptors(GO:1902043) |
| 0.1 |
0.3 |
GO:0007256 |
activation of JNKK activity(GO:0007256) |
| 0.1 |
0.3 |
GO:0031033 |
myosin filament organization(GO:0031033) |
| 0.1 |
3.4 |
GO:0006970 |
response to osmotic stress(GO:0006970) |
| 0.1 |
5.3 |
GO:0051592 |
response to calcium ion(GO:0051592) |
| 0.1 |
0.2 |
GO:0010911 |
regulation of isomerase activity(GO:0010911) positive regulation of isomerase activity(GO:0010912) |
| 0.1 |
0.5 |
GO:0002115 |
store-operated calcium entry(GO:0002115) |
| 0.1 |
0.3 |
GO:0060903 |
positive regulation of meiosis I(GO:0060903) |
| 0.1 |
0.3 |
GO:0006072 |
glycerol-3-phosphate metabolic process(GO:0006072) |
| 0.0 |
0.3 |
GO:0016255 |
attachment of GPI anchor to protein(GO:0016255) |
| 0.0 |
0.2 |
GO:0045654 |
positive regulation of megakaryocyte differentiation(GO:0045654) |
| 0.0 |
0.3 |
GO:0017196 |
N-terminal peptidyl-methionine acetylation(GO:0017196) |
| 0.0 |
2.1 |
GO:0045670 |
regulation of osteoclast differentiation(GO:0045670) |
| 0.0 |
0.4 |
GO:0007168 |
receptor guanylyl cyclase signaling pathway(GO:0007168) |
| 0.0 |
2.9 |
GO:0006888 |
ER to Golgi vesicle-mediated transport(GO:0006888) |
| 0.0 |
0.2 |
GO:0001302 |
replicative cell aging(GO:0001302) |
| 0.0 |
3.0 |
GO:0019722 |
calcium-mediated signaling(GO:0019722) |
| 0.0 |
0.3 |
GO:0010587 |
miRNA catabolic process(GO:0010587) |
| 0.0 |
4.2 |
GO:0007050 |
cell cycle arrest(GO:0007050) |
| 0.0 |
0.2 |
GO:0048102 |
autophagic cell death(GO:0048102) |
| 0.0 |
2.2 |
GO:0097194 |
execution phase of apoptosis(GO:0097194) |
| 0.0 |
0.3 |
GO:0042989 |
sequestering of actin monomers(GO:0042989) |
| 0.0 |
0.2 |
GO:0046416 |
D-amino acid metabolic process(GO:0046416) |
| 0.0 |
1.1 |
GO:0045599 |
negative regulation of fat cell differentiation(GO:0045599) |
| 0.0 |
1.3 |
GO:0048146 |
positive regulation of fibroblast proliferation(GO:0048146) |
| 0.0 |
1.7 |
GO:0050852 |
T cell receptor signaling pathway(GO:0050852) |
| 0.0 |
0.2 |
GO:0060009 |
Sertoli cell development(GO:0060009) |
| 0.0 |
0.7 |
GO:1900452 |
regulation of long term synaptic depression(GO:1900452) |
| 0.0 |
0.2 |
GO:2000786 |
positive regulation of autophagosome assembly(GO:2000786) |
| 0.0 |
4.2 |
GO:0001525 |
angiogenesis(GO:0001525) |
| 0.0 |
0.4 |
GO:1901798 |
positive regulation of signal transduction by p53 class mediator(GO:1901798) |
| 0.0 |
0.3 |
GO:0000042 |
protein targeting to Golgi(GO:0000042) |
| 0.0 |
0.7 |
GO:0051898 |
negative regulation of protein kinase B signaling(GO:0051898) |
| 0.0 |
1.1 |
GO:0010595 |
positive regulation of endothelial cell migration(GO:0010595) |
| 0.0 |
0.9 |
GO:2000134 |
negative regulation of G1/S transition of mitotic cell cycle(GO:2000134) |
| 0.0 |
0.7 |
GO:0048013 |
ephrin receptor signaling pathway(GO:0048013) |
| 0.0 |
0.6 |
GO:0045453 |
bone resorption(GO:0045453) |
| 0.0 |
3.9 |
GO:0006813 |
potassium ion transport(GO:0006813) |
| 0.0 |
0.2 |
GO:0060736 |
prostate gland growth(GO:0060736) |
| 0.0 |
1.1 |
GO:0045638 |
negative regulation of myeloid cell differentiation(GO:0045638) |
| 0.0 |
0.1 |
GO:0046909 |
intermembrane transport(GO:0046909) |
| 0.0 |
0.4 |
GO:0007214 |
gamma-aminobutyric acid signaling pathway(GO:0007214) |
| 0.0 |
1.2 |
GO:0045454 |
cell redox homeostasis(GO:0045454) |
| 0.0 |
0.9 |
GO:0021680 |
cerebellar Purkinje cell layer development(GO:0021680) |
| 0.0 |
0.5 |
GO:0043001 |
Golgi to plasma membrane protein transport(GO:0043001) |
| 0.0 |
0.1 |
GO:0070935 |
3'-UTR-mediated mRNA stabilization(GO:0070935) |
| 0.0 |
1.4 |
GO:0045727 |
positive regulation of translation(GO:0045727) |
| 0.0 |
0.2 |
GO:0045663 |
positive regulation of myoblast differentiation(GO:0045663) |
| 0.0 |
0.8 |
GO:0006493 |
protein O-linked glycosylation(GO:0006493) |
| 0.0 |
0.2 |
GO:0010225 |
response to UV-C(GO:0010225) |
| 0.0 |
1.4 |
GO:0050679 |
positive regulation of epithelial cell proliferation(GO:0050679) |
| 0.0 |
0.6 |
GO:0045766 |
positive regulation of angiogenesis(GO:0045766) |
| 0.0 |
0.6 |
GO:0071346 |
cellular response to interferon-gamma(GO:0071346) |
| 0.0 |
0.1 |
GO:0099515 |
actin filament-based transport(GO:0099515) |
| 0.0 |
0.2 |
GO:0040034 |
regulation of development, heterochronic(GO:0040034) |
| 0.0 |
1.9 |
GO:0048864 |
stem cell development(GO:0048864) |
| 0.0 |
0.6 |
GO:0002088 |
lens development in camera-type eye(GO:0002088) |
| 0.0 |
0.2 |
GO:0032367 |
intracellular cholesterol transport(GO:0032367) |
| 0.0 |
0.3 |
GO:0015701 |
bicarbonate transport(GO:0015701) |
| 0.0 |
0.1 |
GO:0021914 |
negative regulation of smoothened signaling pathway involved in ventral spinal cord patterning(GO:0021914) |
| 0.0 |
0.2 |
GO:0030213 |
hyaluronan biosynthetic process(GO:0030213) |
| 0.0 |
0.1 |
GO:0070813 |
hydrogen sulfide metabolic process(GO:0070813) |
| 0.0 |
0.8 |
GO:0042594 |
response to starvation(GO:0042594) |
